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CASE PRESENTATION
A 78-year-old Caucasian male was referred to our
hypertension clinic in February 2005 for severe blood
pressure (BP) lability. He had a diagnosis of hypertension
for about 10 years, but had been previously well
controlled. Over the preceding 14 months, he had noticed
fluctuations in BP that became progressively more severe.
Based on self-monitored home BP readings, he reported
systolic BP peaks of 220–240 mmHg and systolic BP nadirs
of 80–90 mmHg, often happening within the same day. He
also described that the rise in BP was associated with
significant diaphoresis of the head and palms and facial
flushing, analogous to a ‘thermometer rising inside his
face and head’. Occasionally he also experienced
palpitations. He had erectile dysfunction but no history
of urinary incontinence or retention, or any other
genitourinary complaints. He had no other
cardiopulmonary, digestive, neurological or psychiatric
symptoms. At the time of the initial visit, his hypertension
was managed with labetalol 50 mg that he took
irregularly, on average once daily. In the past, he had
experienced symptomatic hypotension and fatigue with
diltiazem, metoprolol, and diuretics. He did not abuse
alcohol or any illicit substances and did not use any
over-the-counter medications or nutriceuticals.
In addition to hypertension, he had a history of
squamous cell carcinoma of the left pyriform sinus
(treated with extensive radiation to the neck and
chemotherapy in 1998), coronary artery disease (coronary
artery bypass grafting in 2000), nonproteinuric chronic
kidney disease stage 3 (clinically presumed to be due to
hypertensive nephrosclerosis), gastroesophageal reflux,
and well-controlled hypothyroidism. In addition to
labetalol, his medications included aspirin, levothyroxine,
lovastatin, omeprazole, and fish oil.
On examination, the patient appeared well and calm.
BP averaged 184/84 mmHg in the supine position, 152/
78 mmHg when seated, and 140/74 mmHg after 5 min
of orthostasis. His heart rate was 68 b.p.m. and there were
no changes with posture. Fundoscopic examination
revealed arteriolar narrowing and occasional abnormal
arteriovenous crossings. The skin overlying his neck was
taut from previous radiation exposure. There was no
jugular venous distension at 30 degrees. Bilateral carotid
bruits were heard; carotid pulsations were normal.
Examination of the heart, lungs, abdomen, and
extremities were normal. The neurological examination
showed normal focused sensory and motor examination,
without any Parkinsonian or cerebellar features.
Laboratory tests were significant for an elevated serum
creatinine (1.9 mg dl1), with an associated estimated
glomerular filtration rate of 38 ml per min per 1.73 m2.
Relevant laboratory tests, all of which were unremarkable,
are listed in Table 1. A renal sonogram was unremarkable.
A renal magnetic resonance angiogram was normal.
Duplex ultrasound of the carotid arteries revealed
hemodynamically significant bilateral carotid stenosis,
confirmed by magnetic resonance angiography. A
magnetic resonance scan of his brain was remarkable
only for deep white matter ischemic lesions; there
was no evidence of a brain stem lesion or infarct.
Owing to the patient’s history of neck irradiation and
clinical presentation, bedside evaluation of baroreflex
pathway integrity was performed after he had been off
antihypertensive drugs for 5 days. BP averaged 158/
72 mmHg in the supine position, 158/64 mmHg when
seated, and 156/80 in standing. The heart rate was
84 b.p.m. in all positions. The RR interval was unchanged
(0.63 s) during slow deep breathing and throughout the
Valsalva maneuver. We did not use a beat-to-beat
monitor, so we were unable to assess the BP response
to the Valsalva maneuver. The cold pressor test (hand/
forearm immersion) showed an unexpected response:
he had a decline in both heart rate (93–70 b.p.m.) and
BP (154/78–98/60 mmHg), both of which recovered to
baseline levels after 5 min of monitoring. His 24 h
ambulatory BP monitoring is displayed in Figure 1,
demonstrating marked BP lability.
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Clinical diagnosis
We interpreted his presentation as consistent with the
syndrome of baroreflex failure as a result of previous
radiation therapy to the neck.
Clinical follow-up
In the following months, the patient was tried on multiple
antihypertensive regimens including a-methyldopa, lisino-
pril, and hydrochlorothiazine. Similar to labetalol and
metoprolol, these drugs were associated with more marked
hypotensive episodes and still unchanged hypertensive peaks.
We repeatedly offered him a trial of transdermal clonidine,
but he refused it with concerns about intolerance, which he
experienced with a-methyldopa. The regimen that ultimately
proved to best suit him was low-dose felodipine (2.5 mg)
used ‘as-needed’—he takes it about 2–3 times a week. In
September 2005, he underwent bilateral carotid artery
stenting. This intervention did not have any effect on his
clinical behavior. He continues to have extremely labile BP
by home self-monitoring, also confirmed by repeat 24 h
ambulatory BP recordings.
DISCUSSION
Paroxysmal hypertension is a difficult clinical problem that
often leads general internists to seek consultation from
hypertension specialists, including nephrologists. The evalua-
tion of paroxysmal hypertension demands a systematic
approach to rule out the causes listed in Table 2.1,2 In the
case described, we effectively eliminated these possible causes,
with a special focus on pheochromocytoma, renal artery
stenosis, and a central nervous system lesion involving
the brain stem. We ultimately ascribed the lability of his BP
to baroreflex failure due to his previous neck irradiation.
Although uncommon (two patients in a large series of
688 patients with paroxysmal hypertension2), baroreflex
failure is an important etiology to consider, given its unique
Table 1 | Relevant laboratory test results
Creatinine 1.9 mg dl1 PTH 52.5 pg ml1
Urea nitrogen 25 mg dl1 TSH 3.64 mIU ml1
Estimated GFR 38 ml per min per 1.73 m2 Plasma metanephrines (total) 305 pg ml1
Sodium 139 mmol l1 24-h urine catecholaminesa
Potassium 3.9 mmol l1 Epinephrine (per 24 h) o2 mg, 7 mg, o2 mg
Bicarbonate 27 mmol l1 Norepinephrine (per 24 h) 23 mg, 23 mg, 47mg
Chloride 103 mmol l1 Metanephrines (per 24 h) 66 mg, 170mg, 165mg
Calcium 9.2 mg dl1 Nor-metanephrines (per 24 h) 244mg, 233mg, 383mg
Phosphorus 2.5 mg dl1 VMA (per 24 h) 5.9 mg, 4.3 mg, 8.3 mg
Albumin 4.2 mg dl1 Dopamine (per 24 h) 124mg, 146mg, 173mg
WBC 8,900ml1 Plasma renin activity 2.1 ng ml1 h1
Hemoglobin 14.4 g dl1 Serum aldosterone 7 ng dl1
MCV 95 fl
Platelets 262 000ml1
GFR, glomerular filtration rate (modification of diet in renal disease equation); MCV, mean corpuscular volume; PTH, parathyroid hormone; TSH, thyroid-stimulating hormone;
VMA, vanillylmandelic acid; WBC, white blood cell count.
aUrine catecholamine profile was collected on three separate occasions. Values are listed in sequence for each of the collections.
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Figure 1 | Twenty-four-hour ambulatory BP recording. Average 24 h BP 110/51 mmHg (heart rate 73 b.p.m.); BP 115/54 mmHg (heart
rate 74 b.p.m.) when awake, BP 98/44 mmHg (heart rate 73 b.p.m.) when asleep. Notice the highly variable BP with sudden pressor and
depressor episodes with blunted heart rate variability (corroborated by the 24 h standard deviations were 30 mmHg for systolic BP,
15 mmHg for diastolic BP, and 7 b.p.m. for heart rate). The patient slept from 2330 to 0700 hours.
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mechanistic and clinical features. In this article, we review
the general approach to the diagnosis of baroreflex failure,
the role of iatrogenic neck injury in causing the syndrome,
the potential relevance of carotid atherosclerosis and its treat-
ment on the clinical course, and available treatment options.
An overview of baroreflex failure
The arterial baroreflex buffers abrupt changes in BP and
prevents pressure from rising or falling excessively through
adjustments in heart rate, cardiac contractility, and vascular
tone.1,2 The hypertensive effect of loss of baroreflex function
in humans was first demonstrated through experiments in
both normotensive and hypertensive patients in the 1930s.3
In these studies, unilateral carotid sinus anesthesia caused
modest increases in BP (10–40 mmHg), whereas bilateral
anesthesia resulted in uniform pressor responses of as much
as 100 mmHg accompanied by large increases in heart rate,
cardiac output, and systemic vascular resistance.3
Baroreceptors located in the carotid sinuses, aortic arch,
and great vessels of the thorax transmit afferent signals to
the nucleus tractus solitarii in the dorsal medulla via the
glossopharyngeal (cranial nerve IX) and vagal nerves (cranial
nerve X) (Figure 2). The nucleus tractus solitarii also receives
cortical input derived from environmental stimuli. The
efferent pathway consists of inhibitory sympathetic rostral
ventrolateral medullary area and excitatory sympathetic
raphe nucleus and parasympathetic nucleus ambiguous in
the medulla, supplying fibers to the heart as well as to smooth
muscles in the peripheral blood vessels.1 This adaptation
is especially important for minute-to-minute BP control,
although it is possible that baroreflexes are also important
in chronic BP regulation.4 When challenged with a rise in
BP, heart rate falls due to an increase in parasympathetic
tone and a decrease in sympathetic tone, which also results
in decreased vasoconstriction. In patients with baroreflex
failure, pressor episodes are associated with increased plasma
norepinephrine, suggesting that they are mediated by
‘unrestrained activation’ of the sympathetic nervous system.5
Impairment of baroreflex may produce an unusually
broad spectrum of clinical presentations. Possible causes are
listed in Table 3.1–3,6 If a specific causative event is present,
such as recent trauma to the carotid arteries, this syndrome is
characterized by acute malignant hypertension and tachy-
cardia followed by labile hyper- and hypotension. Common
symptoms of baroreflex failure include dramatic fluctuations
of sympathetic activity, resulting in paroxysms of arterial
hypertension, tachycardia, diaphoresis, headache, flushing,
and emotional instability resembling the symptoms of
pheochromocytoma.5 An important factor in the differential
diagnosis with other syndromes of autonomic dysfunction
is the uncommon occurrence of orthostatic hypotension in
baroreflex failure.5,7
Four distinct clinical presentations have been described in
the literature (reviewed in detail by Ketch et al.1). Hyper-
tensive crisis (sometimes associated with apneic spells) is
the most common acute presentation. Volatile hypertension
is the common subacute or chronic form of nonselective
(sympathetic and parasympathetic) baroreflex failure. Two
Table 2 | Causes of paroxysmal hypertension relevant to the
differential diagnosis of baroreflex failure
Pheochromocytoma
Pseudopheochromocytoma (Page syndrome)
Hyperthyroidism
Renal artery stenosis
Primary reninism (reninoma)
Mastocytosis
Carcinoid
Medications/nutriceuticals: sympathomimetic amines
(phenylpropanolamine, pseudoephedrine, ephedra, midodrine),
yohimbine, monoaminooxidase A inhibitors (exposed to tyramine),
clonidine withdrawal in hypertensive patients, sibutramine, 5-HT agonists
Substance abuse: amphetamines, cocaine, alcohol
Alcohol withdrawal
Intracranial hypertension: mass lesions, inflammatory disorders
Neurohypertensive syndrome of brainstem compression
Panic disorder
Generalized anxiety disorder
Migraine
Baroreflex failure
Adapted from references 1 and 2.
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Figure 2 | Schematic of the anatomy and pathways of the normal
baroreflex arc. PNS, parasympathetic nervous system; SNS,
sympathetic nervous system; Ach, acetylcholine; NE, norepinephrine;
HR, heart rate; and BP, blood pressure. Reproduced with
permission from Ketch et al.1
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other syndromes may occur in rare cases of selective baro-
reflex failure: orthostatic tachycardia due to selective sympa-
thetic dysfunction, and malignant vagotonia due to selective
parasympathetic dysfunction.1 In addition, a noteworthy
phenomenon of pseudobaroreflex failure can occur with
intermittent clonidine intake.8
Sustained baroreflex failure occurs after bilateral damage
to the carotid and aortic baroreceptors, which is usually
related to neck surgery (carotid endarterectomy and carotid
body tumor resection) or neck irradiation for malignant
tumors.1 Additionally, brain stem infarctions or lesions
involving the nucleus tractus solitarii can result in the
syndrome.1,5
The marked redundancy of baroreceptor afferents can
explain the rarity of full-blown baroreflex failure.9 Kuchel
identified two cases among 688 patients referred with
paroxysmal hypertension,2 63 of whom had the syndrome
of pseudopheochromocytoma in which the clinical presenta-
tion was suggestive of pheochromocytoma but the bio-
chemical and imaging evaluation was negative.10 At a
national referral center on autonomic disorders, only 11
cases were identified among approximately 500 patients.5
However, depending upon the patient cohort, this syndrome
may also be underdiagnosed. For example, in patients
undergoing bilateral carotid body tumor resection, the
development of postoperative baroreceptor function varies
between 17 and 100% in the literature,11,12 likely a reflection
of the different degrees of awareness and investigation.
Key clinical features of baroreflex failure can be uncovered
with a careful clinical examination. A history of iatrogenic
trauma of the neck is the most important clue. After exclu-
ding other possible causes of paroxysmal hypertension
(outlined in Table 2), the diagnosis should be further
established by noninvasive bedside cardiovascular autonomic
testing (Table 413,14). Although the evaluation of the auto-
nomic nervous system can be quite extensive, a structured
initial assessment at the bedside using specific maneuvers
and a cardiac monitor can provide detailed information.
This evaluation includes the assessment of BP responses
to orthostasis, mental stress, handgrip, and cold stimulation
as well as evaluation of the heart rate and RR-interval
Table 3 | Causes of baroreflex failure
Surgical manipulation of the carotid arteries (typically bilateral)
Endarterectomy
Carotid body tumor resection
Direct trauma to the neck/carotid arteries
Ionizing radiation-induced damage to the carotid arteries
Inflammatory damage to the carotid arteries and aorta: Takayasu’s arteritis
Dysfunction of the carotid sinus nerve
Groll–Hirschowitz syndrome
Brain stem damage (to the nucleus tractus solitarii bilaterally)
Infarction
Tumor
Vascular compression
Aging/arteriosclerosis
Monogenic syndrome of hypertension with brachydactyly
Compiled from references 1, 2, 3, and 6.
Table 4 | Useful tests in the evaluation of patients with suspected baroreflex dysfunction
Test Normal response Part of baroreflex arc tested Response in baroreflex failure
BP response to standing BP k o20/10 mmHg Integrated afferent and efferent Normal, as dysfunction is related
to BP increase, not decline
HR m o20 b.p.m.
Valsalva maneuver Long/short R:R ratio X1.45 Integrated afferent and efferent Blunted phases II and IV
Phase I: mBP
Phase 11: kBP, mHR
Phase 111: further kBP
Phase IV: BP overshoot, mHR
Respiratory sinus arrhythmia (slow
deep breathing)
m HR, E:I ratio of RR int 41.2 Afferent and efferent parasympathetic Normal or blunted
Cold face test (Trigeminovagal
reflex)
Bradycardia Efferent parasympathetic Normal or blunted
Mental arithmetic m BP and HR Efferent sympathetic and cortical input Normal or enhanced
Isometric exercise (handgrip) m BP and HR Efferent sympathetic Normal or enhanced
Cold pressor test m BP and HR Efferent sympathetic Normal or enhanced
Combined analysis of spontaneous
BP and HR fluctuations
k HR (m RR int) when BPm Integrated afferent and efferent Blunted
m HR (k RR int) when BPk
Nitroprusside infusion m HR Afferent and efferent parasympathetic Blunted HR response; excessive
BP fall
Phenylephrine infusion k HR Afferent and efferent parasympathetic Blunted response; excessive BP
rise
Plasma catecholamines Depends on challenge Efferent sympathetic Increased
Sympathetic microneurography Depends on challenge Efferent sympathetic Increased
BP, blood pressure; HR, heart rate; E:I, expiration/inspiration ratio; RR int, RR interval on EKG.
Based on references 13 and 14.
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responses to slow deep breathing and the Valsalva maneuver.
If a noninvasive monitor of beat-to-beat BP variability is
available (for example, Finapres, Portapres), the evaluation is
more precise, as the BP responses to the Valsalva and other
maneuvers can be accurately assessed. Table 4 provides a
general guide for the interpretation of these tests (we refer the
reader to the bibliography listed in the table for details
on how to perform and interpret each test). Sympathetic
efferent fibers to the vasculature and to the heart are typically
(but not always) intact in baroreflex-failure patients. There-
fore, these patients exhibit a normal or enhanced pressor
response to cold mental stress and handgrip testing.5 Our
patient probably had associated efferent dysfunction of the
reflex arc, which explains his paradoxical response to the cold
pressor test. Respiratory heart rate variability is typically
reduced in nonselective baroreflex failure because para-
sympathetic efferent fibers to the heart are damaged. A 24 h
BP recording often demonstrates the magnitude of BP lability
and is helpful in diagnosis and follow-up. More specialized
tests include beat-to-beat spectral analysis of spontaneous
heart rate and systolic BP variability,13 the BP and heart rate
responses to phenylephrine or nitroprusside, and sympa-
thetic microneugraphy.5 These tests are typically available
only at referral centers for autonomic disorders.
Iatrogenic neck injury as a cause of baroceptor failure
Damage to the neck in areas surrounding the carotid arteries
is a well-established cause of baroceptor failure.1,5,15 Such
injury is typically iatrogenic, related to direct manipulation
of the common carotid artery during operations or to slowly
progressive fibrotic injury to the carotids following neck
irradiation.
In case of damage induced by neck irradiation, baroreflex
failure tends to occur after an interval of months to years
after the irradiation. The presumptive pathophysiologic
mechanisms include accelerated local arteriosclerosis, encase-
ment of small afferent fibers by fibrotic tissue, and vascular
wall injury due to damage to vasa vasorum.16–18 The
incidence of this late complication may be increasing due
to improved long-term survival of these patients.1,19
Extensive radiation fields resulting in bilateral injury to
carotid bulbs typically produce the syndrome. However, a
recent paper reported a case of the full-blown syndrome
following unilateral radiation without evidence of structural
damage to the contralateral side.19 The overall incidence of
the full-blown syndrome is not known, but is probably low.
Although patients who have undergone cervical irradiation
have impaired baroreflex sensitivity compared with age-
matched controls, baroreflex failure is a rare occurrence.18
Effects of carotid atherosclerosis and its treatment on
baroceptor function
Carotid artery atherosclerosis measured as intima-media
thickness at the level of the carotid bulb is associated
with impaired baroreflex sensitivity.20 Available data suggest
that this effect requires advanced disease, especially with
circumferential involvement of the vessel.21 Studies on the
effect of treatment of carotid stenosis with endarterectomy
on baroreflex function have yielded conflicting results. The
initial assumption was that correction of the atherosclerosis
would result in improved baroreflex; however, long-term
studies indicate that there is either no effect22 or a decreased
response.23 Therefore, it appears that any damage induced to
baroreceptors during the development of carotid stenosis
is not amenable to improvement, likely due to the trauma
caused by the intervention itself. In our patient, the diagnosis
of severe bilateral carotid stenosis demanded intervention
with the goal of preventing strokes. Percutaneous stenting did
not result in any improvement in his clinical status.
Treatment options in chronic baroceptor failure
Information on the treatment of baroreflex failure is scarce
and relies on observational case studies and expert opinion.
The main goal of therapy is to minimize the frequency and
magnitude of both hypertensive and hypotensive episodes.
Antiadrenergic drugs are viewed as the preferable agents for
treatment. Centrally acting agents such as clonidine and
methyldopa decrease sympathetic activity, cause mild seda-
tion, and attenuate BP surges. Robertson et al.5 reported
significant improvement in frequency and severity of attacks
with clonidine, as well as decline in plasma catecholamine
levels during surges in the treated patients. Peripherally
acting sympatholytic agents such as guanethidine and guana-
drel have also been used successfully in patients who do not
tolerate the sedative effects of clonidine or methyldopa.7
Some authors are concerned about the use of vasodilator
drugs, as they may cause excessive hypotension.7
Interestingly, a calcium-channel blocker was the drug
best tolerated by our patient, although still not fully effective.
It was selected through a process of trial and error that is
often required in these patients, although others have also
used these drugs successfully.9,24 The natriuretic effects of
calcium-channel blockers could have resulted in mild volume
depletion and mitigation of further hypertensive episodes
without necessarily inducing an increase in hypotensive
events.25 However, we do not know what the counter-
balancing effect of increased sympathetic function on BP
behavior would be, as calcium-channel blockers are well
known to increase sympathetic tone.
Benzodiazepines can be used to suppress the unopposed
cortical input, especially the acute phase of baroreflex
failure.5,24 Additional nonpharmacological strategies include
avoidance of individual factors that evoke sympathetic surges
and biofeedback (relaxation) training.7
Medications that may change sympathetic activity or
vascular tone, including a variety of over-the-counter drugs,
must be used with great caution in susceptible individuals.
Agents that increase synaptic norepinephrine concentrations
may elicit profound pressor responses and should be avoided
in baroreflex failure. These include tricyclic antidepressants,
amphetamines, monoaminooxidase A inhibitors, cocaine,
and tyramine-containing foods and beverages.15
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In summary, baroreflex failure is a condition that, although
uncommon, must be considered in patients with paroxysmal
hypertension. Its diagnosis is not always straightforward, its
natural course is unpredictable, and its treatment is challen-
ging; thus, frequent patient monitoring and pathophysiology-
based approaches to therapy are needed in the attempt to
minimize BP oscillations and optimize patient outcomes.
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